Michael A. Goetz
12Patents
4h-index
41Co-inventors
60Inventor score
Filing activity: Dec 7, 1981 → Dec 17, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5631282A | Triterpenes | Human Necessities | 32 | Expired |
| US5352800A | Process for the production of a novel endothelin antagonist | Emerging Cross-Sectional Technologies | 31 | Expired |
| US4530790A | Cholecystokinin antagonists | Emerging Cross-Sectional Technologies | 7 | Expired |
| US4390546A | Antiparasitic macrolide from a strain of Streptomyces hygroscopicus | Chemistry; Metallurgy | 5 | Expired |
| US5620953A | Antiprotozoal cyclic tetrapeptides | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5095003A | Oxytocin and vasopressin antagonists | Chemistry; Metallurgy | 2 | Expired |
| US4695544A | Process for the preparation of cholecystokinin antagonists | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7294646B2 | Maxi-k channel blockers, methods of use and process for making the same | Chemistry; Metallurgy | 2 | Expired |
| US4696925A | Cholecystokinin antagonist compounds | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5276054A | Substituted hexahydrobenzopyran derivatives as angiotensin II antagonists | Chemistry; Metallurgy | 1 | Expired |
| US5861375A | Antiprotozoal cyclic tetrapeptides | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9126983B2 | Extracts from kibdelos porangium as antibacterial agents | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.